Shenzhen - Delayed Quote CNY
Jilin Jian Yisheng Pharmaceutical Co., Ltd. (002566.SZ)
7.23
+0.15
+(2.12%)
At close: 3:04:24 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
627.21M
668.47M
853.66M
830.04M
877.93M
Cost of Revenue
164.23M
170.64M
224.20M
216.53M
220.54M
Gross Profit
462.98M
497.83M
629.46M
613.52M
657.39M
Operating Expense
412.20M
439.55M
523.59M
505.55M
524.74M
Operating Income
50.78M
58.28M
105.87M
107.97M
132.66M
Net Non Operating Interest Income Expense
-11.49M
-7.57M
896.28k
-5.92M
-4.36M
Pretax Income
48.85M
59.55M
111.76M
101.23M
123.37M
Tax Provision
7.57M
8.89M
15.65M
12.91M
18.67M
Net Income Common Stockholders
42.93M
52.09M
94.73M
83.10M
96.02M
Basic EPS
0.13
--
0.29
0.25
0.29
Diluted EPS
0.13
--
0.29
0.25
0.29
Basic Average Shares
331.01M
--
331.00M
330.93M
330.99M
Diluted Average Shares
331.01M
--
331.00M
330.93M
330.99M
Total Operating Income as Reported
49.31M
61.36M
115.73M
102.66M
128.63M
Total Expenses
576.43M
610.19M
747.80M
722.08M
745.27M
Net Income from Continuing & Discontinued Operation
42.93M
52.09M
94.73M
83.10M
96.02M
Normalized Income
37.12M
47.52M
88.43M
85.12M
95.81M
Interest Income
2.92M
6.41M
14.67M
8.20M
9.19M
Interest Expense
14.24M
13.84M
13.66M
14.03M
13.36M
Net Interest Income
-11.49M
-7.57M
896.28k
-5.92M
-4.36M
EBIT
63.09M
73.39M
125.42M
115.26M
136.73M
EBITDA
63.09M
120.47M
174.35M
159.53M
179.82M
Reconciled Cost of Revenue
164.23M
170.64M
224.20M
216.53M
220.54M
Reconciled Depreciation
--
47.08M
48.93M
44.27M
43.09M
Net Income from Continuing Operation Net Minority Interest
42.93M
52.09M
94.73M
83.10M
96.02M
Total Unusual Items Excluding Goodwill
6.88M
5.37M
7.33M
-2.32M
248.02k
Total Unusual Items
6.88M
5.37M
7.33M
-2.32M
248.02k
Normalized EBITDA
56.22M
115.10M
167.02M
161.85M
179.57M
Tax Rate for Calcs
0.16
0.15
0.14
0.13
0.15
Tax Effect of Unusual Items
1.07M
801.50k
1.03M
-295.73k
37.54k
12/31/2021 - 3/18/2011
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade